Skip to content

Efficacy of monoterpene Perillyl alcohol upon survival rate of patients with recurrent glioblastoma

This study tested the effectiveness of Perillyl Alcohol Inhalation for 89 patients experiencing recurrent glioblastoma and compared survival rates for those receiving the treatment to 52 patients receiving the traditional supportive modalities.

Those receiving Perillyl Alcohol lived longer and experienced little-to-no side effects even after four years of use.

Share on facebook
Share on email
Share on twitter
Share on linkedin

More on Perillyl Alcohol

Notify of
Inline Feedbacks
View all comments